Blood and Immunity Practice Questions

Q: Hematocrit relates to which of the following?

Total RBC volume. **Explanation:** **Hematocrit (Hct)**, also known as **Packed Cell Volume (PCV)**, is defined as the percentage of the total blood volume that is occupied by red blood cells (RBCs). When a blood sample is centrifuged, the heavier cells settle at the bottom. Since RBCs constitute approximately 99% of the cellular elements in blood, the PCV is a direct reflection of the **Total RBC volume**. * **Why Option B is correct:** Hematocrit specifically measures the volume of erythrocytes relative to the whole blood. In a healthy adult, this is approximately 45% (40-50% in males; 38-45% in females). * **Why Option A is incorrect:** Total blood volume includes both the cellular components (RBCs, WBCs, Platelets) and the plasma. Hematocrit is a *ratio* or *percentage* of this volume, not the volume itself. * **Why Option C is incorrect:** WBCs and platelets form a very thin layer between the plasma and RBCs called the **"Buffy Coat"** (usually <1% of total volume). * **Why Option D is incorrect:** Plasma filtrate refers to the fluid that passes through capillary walls into the interstitial space; it is not measured by hematocrit. **High-Yield Clinical Pearls for NEET-PG:** 1. **Wintrobe’s Tube:** The standard instrument used to determine PCV. 2. **Rule of Three:** In a normal individual, Hemoglobin (g/dL) × 3 ≈ Hematocrit (%). 3. **Clinical Variations:** * **Increased Hct:** Seen in Polycythemia and **Dehydration** (due to hemoconcentration). * **Decreased Hct:** Seen in Anemia and Pregnancy (due to hemodilution, as plasma volume increases more than RBC mass). 4. **Body Hematocrit vs. Venous Hematocrit:** The "Body Hematocrit" (average Hct of all vessels) is usually slightly lower (about 91%) than the "Venous Hematocrit" measured from a peripheral vein.

Q: Which of the following is the major site of erythropoietin production during the fetal stage?

Liver. **Explanation:** The production of **Erythropoietin (EPO)**, the primary hormone regulating red blood cell production, undergoes a significant site transition during development. 1. **Why Liver is Correct:** During the **fetal stage**, the **liver** is the primary source of erythropoietin (approximately 80-90%). While the kidneys begin producing EPO toward the end of gestation, the liver remains the dominant site until shortly after birth, when the production site shifts to the peritubular interstitial cells of the renal cortex. 2. **Why Other Options are Incorrect:** * **Yolk sac:** This is the site of the first wave of hematopoiesis (mesoblastic stage), but it does not serve as the primary site for EPO production. * **Bone (Bone Marrow):** While the bone marrow is the primary site of *erythropoiesis* (RBC production) from the 5th month of gestation onwards, it is not a site for EPO *synthesis*. * **Spleen:** The spleen is an extramedullary hematopoietic organ during the fetal period (hepatic stage), but its contribution to EPO production is negligible compared to the liver. **High-Yield Clinical Pearls for NEET-PG:** * **Adult Site:** In adults, **90%** of EPO is produced by the **Kidneys** (Peritubular interstitial cells) and 10% by the Liver. * **Stimulus:** The primary stimulus for EPO release is **hypoxia** (detected by HIF-1α). * **Fetal vs. Adult:** The fetal liver is less sensitive to hypoxia than the adult kidney, which is one reason why fetal erythropoiesis is maintained at a steady rate. * **Chronic Kidney Disease (CKD):** Anemia in CKD is primarily due to the loss of EPO-producing cells in the kidney.

Q: At what age do infants typically reach adult hemoglobin levels?

By the end of the first year of life. **Explanation:** The transition from fetal to adult hemoglobin is a critical physiological process. Fetal hemoglobin (**HbF**, $\alpha_2\gamma_2$) has a high affinity for oxygen, which is essential for oxygen extraction from maternal blood in utero. After birth, as the infant begins breathing atmospheric air, the production of gamma ($\gamma$) chains is suppressed, and the synthesis of beta ($\beta$) chains increases, leading to the formation of adult hemoglobin (**HbA**, $\alpha_2\beta_2$). **Why the correct answer is right:** The "hemoglobin switch" begins before birth, but the most rapid decline in HbF occurs during the first six months of life. By **6 to 12 months of age**, HbF levels typically drop to less than 1–2%, which is the standard adult level. Therefore, by the end of the first year, the hemoglobin profile is indistinguishable from that of an adult. **Why other options are incorrect:** * **At birth:** HbF accounts for approximately 60–80% of total hemoglobin at birth. * **By four years of age:** While minor fluctuations occur, adult levels are reached much earlier (by age 1). * **At puberty:** Hemoglobin *concentration* (grams/dL) increases during puberty due to testosterone in males, but the *type* of hemoglobin (HbA) is established in infancy. **NEET-PG High-Yield Pearls:** * **P50 Value:** HbF has a lower P50 (approx. 19 mmHg) compared to HbA (approx. 27 mmHg), reflecting its higher oxygen affinity. * **2,3-BPG:** HbF binds poorly to 2,3-BPG, which is the primary reason for its high oxygen affinity. * **Clinical Correlation:** Beta-thalassemia and Sickle Cell Anemia symptoms typically manifest after 6 months of age, coinciding with the physiological decline of protective HbF.

Q: Which interleukin is needed for differentiation of eosinophils?

IL5. **Explanation:** The differentiation, maturation, and activation of eosinophils are primarily regulated by **Interleukin-5 (IL-5)**. Produced mainly by Th2 cells, IL-5 acts as the most specific growth factor for the eosinophil lineage. It stimulates the bone marrow to increase eosinophil production (eosinopoiesis) and is essential for their survival and chemotaxis to sites of inflammation. **Analysis of Options:** * **IL-1:** A pro-inflammatory cytokine primarily produced by macrophages. It acts as an endogenous pyrogen (induces fever) and stimulates the acute phase response, but does not specifically drive eosinophil differentiation. * **IL-2:** Known as the "T-cell growth factor." It is essential for the proliferation and clonal expansion of T-lymphocytes and the activation of Natural Killer (NK) cells. * **IL-4:** While IL-4 is involved in the Th2 response and promotes B-cell class switching to **IgE**, it is not the primary driver for eosinophil differentiation. It works upstream to IL-5 by inducing Th2 cell development. **High-Yield NEET-PG Pearls:** * **Mnemonic:** Remember **"IL-5 drives the E-osinophil"** (5 looks like an 'S', and Eosinophils are associated with 'S'ensitivity/Allergy). * **Clinical Correlation:** **Mepolizumab** and **Reslizumab** are monoclonal antibodies against IL-5 used in the treatment of severe eosinophilic asthma. * **Eosinophilia:** Characteristically seen in **NAACP**: **N**eoplasia, **A**sthma/Allergy, **A**ddison’s disease, **C**onnective tissue disorders, and **P**arasitic infections. * **Major Basic Protein (MBP):** The primary constituent of eosinophil granules responsible for killing helminths.

Q: Anti-A and anti-B antibodies appear in a child when?

After 6 months of birth. **Explanation:** The development of ABO antibodies (isoagglutinins) is a classic high-yield topic in hematology. **1. Why Option D is Correct:** At birth, a newborn’s serum contains almost no self-produced antibodies. The anti-A and anti-B antibodies are **IgM** type, which do not cross the placenta. While some maternal IgG antibodies may be present, the infant’s own production of anti-A and anti-B begins only after exposure to environmental antigens (found in food and gut bacteria) that mimic A and B antigens. The titer of these antibodies remains very low until **2 to 8 months (average 6 months)** after birth, reaching peak levels between ages 8 and 10. **2. Why Other Options are Incorrect:** * **Option A & B:** At birth and during the first week, the infant is "immunologically naive" regarding ABO antibodies. Any antibodies detected are usually maternal IgG that crossed the placenta, not the infant's own isoagglutinins. * **Option C:** While the immune system begins to mature by 6 weeks, the concentration of anti-A and anti-B is still negligible and usually undetectable by standard laboratory agglutination tests at this stage. **3. NEET-PG High-Yield Pearls:** * **Antibody Type:** Naturally occurring anti-A and anti-B are primarily **IgM** (cannot cross placenta). In contrast, the antibodies in an O-type mother are often **IgG**, which explains why ABO incompatibility can affect a first-born child (unlike Rh incompatibility). * **Landsteiner’s Law:** States that if an agglutinogen (antigen) is present on RBCs, the corresponding agglutinin (antibody) must be absent. This law applies to the ABO system but **not** to the Rh system. * **Clinical Significance:** Because these antibodies are absent at birth, forward grouping (cell grouping) is reliable in neonates, but **reverse grouping (serum grouping)** is unreliable and not routinely performed until the child is older.

Q: Hagemann factor is involved in which pathway of coagulation?

Intrinsic pathway. **Explanation:** The **Hagemann Factor (Factor XII)** is a plasma protein that plays a pivotal role in the initiation of the **Intrinsic Pathway** of the coagulation cascade. 1. **Why Option B is Correct:** The intrinsic pathway begins when Factor XII comes into contact with negatively charged surfaces (such as collagen, glass, or kaolin). This "contact activation" converts inactive Factor XII into Factor XIIa. Once activated, Factor XIIa triggers a proteolytic cascade by activating Factor XI, which subsequently activates Factor IX, eventually leading to the common pathway. 2. **Why Other Options are Incorrect:** * **Extrinsic Pathway (A):** This pathway is initiated by **Tissue Factor (Factor III)** and Factor VII following vascular injury. It does not require Factor XII. * **Fibrinolysis (C):** While Factor XIIa can indirectly influence the conversion of plasminogen to plasmin, its primary and diagnostic role in the coagulation cascade is the initiation of the intrinsic pathway. * **None (D):** Incorrect, as Factor XII is a well-established component of the clotting system. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **The Hagemann Paradox:** Interestingly, patients with a deficiency of Factor XII **do not bleed** clinically. Instead, they may show a prolonged **Activated Partial Thromboplastin Time (aPTT)** in lab tests and may actually have a higher risk of thrombosis. * **Link to Inflammation:** Factor XIIa also converts prekallikrein to **kallikrein**, which leads to the production of **bradykinin** (a potent vasodilator). This links the coagulation system to the kinin system and inflammation. * **Sequence of Intrinsic Pathway:** XII → XI → IX → VIII (Remember: 12, 11, 9, 8).

Q: Bleeding time is not prolonged in which of the following conditions?

Polycythemia. **Explanation:** **Bleeding Time (BT)** is a clinical test that measures the time taken for a small skin wound to stop bleeding. It is primarily a measure of **primary hemostasis**, which depends on two factors: **Platelet function** (count and quality) and **Vascular integrity**. **Why Polycythemia is the correct answer:** Polycythemia involves an increase in the total red blood cell mass. While it can lead to hyperviscosity and a paradoxical risk of both thrombosis and bleeding (due to acquired von Willebrand syndrome in extreme cases), it does **not** characteristically prolong the Bleeding Time. In many cases of Polycythemia Vera, the platelet count is actually elevated (thrombocytosis), which would keep the BT within normal limits. **Analysis of Incorrect Options:** * **Von Willebrand’s Disease (vWD):** This is the most common inherited bleeding disorder. vWF is essential for platelet adhesion to the subendothelium. Deficiency leads to impaired primary hemostasis, resulting in a **prolonged BT**. * **Haemophilia A & Christmas Disease (Haemophilia B):** These are disorders of **secondary hemostasis** (deficiency of Factor VIII and IX, respectively). While they characteristically prolong the **Clotting Time (CT/aPTT)**, they often show a normal BT. However, in the context of this specific MCQ, Polycythemia is the "most correct" answer because vWD *always* affects BT, and severe Haemophilia can sometimes show borderline BT elevations, whereas Polycythemia is fundamentally not a disorder of primary hemostasis. **High-Yield Clinical Pearls for NEET-PG:** * **Bleeding Time (BT):** Normal range 2–7 minutes (Ivy’s method). Reflects Platelets. * **Clotting Time (CT):** Normal range 5–11 minutes. Reflects Coagulation Factors. * **Aspirin:** Prolongs BT by irreversibly inhibiting COX-1 (anti-platelet effect). * **Glanzmann Thrombasthenia:** Normal platelet count but **prolonged BT** due to GpIIb/IIIa deficiency.

Question 1

Hematocrit relates to which of the following?

Accepted Answer

Total RBC volume

Answer

Total blood volume

Answer

Total WBC volume

Answer

Plasma filtrate

Question 2

Which of the following is the major site of erythropoietin production during the fetal stage?

Accepted Answer

Liver

Answer

Yolk sac

Answer

Bone

Answer

Spleen

Question 3

At what age do infants typically reach adult hemoglobin levels?

Accepted Answer

By the end of the first year of life

Answer

At birth

Answer

At puberty

Answer

By four years of age

Question 4

Which of the following is a feature of a reticulocyte?

Accepted Answer

No nucleus

Answer

Constitute 10% of the red cells

Answer

Smaller in size than RBCs

Answer

Mature in lymph nodes

Question 5

Which interleukin is needed for differentiation of eosinophils?

Accepted Answer

IL5

Answer

IL1

Answer

IL2

Answer

IL4

Question 6

Which of the following situations will lead to increased viscosity of blood?

Accepted Answer

Multiple myeloma

Answer

Fasting state

Answer

Hypoglycemia

Answer

Amyloidogenesis

Question 7

A 40-year-old female patient complains of excessive bleeding following a road traffic accident 5 hours ago, with a lacerated wound on the lower back. Blood grouping tests reveal the presence of antigen A and antigen H. Anti-RhD antibodies and anti-B antibodies are also present. Which donor blood group can this patient receive transfusion from?

Accepted Answer

Bombay blood group

Answer

A positive

Answer

O positive

Answer

B negative

Question 8

Anti-A and anti-B antibodies appear in a child when?

Accepted Answer

After 6 months of birth

Answer

Just after birth

Answer

1 week after birth

Answer

6 weeks after birth

Question 9

Hagemann factor is involved in which pathway of coagulation?

Accepted Answer

Intrinsic pathway

Answer

Extrinsic pathway

Answer

Fibrinolysis

Answer

None

Question 10

Bleeding time is not prolonged in which of the following conditions?

Accepted Answer

Polycythemia

Answer

Von Willebrand's disease

Answer

Christmas disease

Answer

Haemophilia

Blood and Immunity — MCQs

Blood and Immunity — MCQs

On this page

Practice by Chapter

Want unlimited practice?